₨ Official source-observed price
PKR 25,715.63
1's
PKR 25,715.63 / vial/unit
✓ Official DRAP price source observed · Source checked 2026-08-27
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 25,715.63/ vial/unit
Price positionNo comparatorvs like-for-like peer median
Peer comparators0current-price listings
Normalized unit pricePKR 25,715.63 / vial/unit
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Bevacizumab
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01
- Strength
- 100 mg/4 mL
- Dosage form
- Solution for infusion
- Pack
- 1's
- Registration no.
- 120492
- Price record verified
- 2026-08-27
- Latest DRAP source check
- 2026-08-27 02:56
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 25,715.63 | 2026-07-23 | 2026-08-27 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
ABEVMY 100 mg/4 mLAGP Limited · PKR 25,715.62Abevmy 400 400 mg/16 mL (25 mg/mL)AGP LimitedArketin 100 mg/4 mLRA Healthcare (SMC-Pvt) Ltd · PKR 17,674.07Avastin 400 mg/16 mLRoche Pakistan Ltd · PKR 236,486.52Avastin 100 mg/4 mLRoche Pakistan Ltd · PKR 59,483.08Avastin 400 mg/16 mLRoche Pakistan Ltd · PKR 236,486.52BAZUMAB 100 mg/4 mLHilton Pharma (Pvt) Limited. · PKR 23,067.95BAZUMAB 400 mg/16 mLHilton Pharma (Pvt) Limited. · PKR 91,711.79
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 120492MedInfoBase. (2026). Cizumab EU 100 mg/4 mL Solution for infusion (1's), The Searle Company Limited — registration and price record [Data set]. MedInfoBase. Retrieved September 18, 2026, from https://medinfobase.com/brand/cizumab-eu-100-mg-4-ml-120492-1s-the-searle-company-limited/ Data observed 27 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 120492.
MedInfoBase. Cizumab EU 100 mg/4 mL Solution for infusion (1's), The Searle Company Limited — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 18]. Available from: https://medinfobase.com/brand/cizumab-eu-100-mg-4-ml-120492-1s-the-searle-company-limited/ Data observed 27 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 120492.
MedInfoBase (2026) Cizumab EU 100 mg/4 mL Solution for infusion (1's), The Searle Company Limited — registration and price record. Available at: https://medinfobase.com/brand/cizumab-eu-100-mg-4-ml-120492-1s-the-searle-company-limited/ (Accessed: 18 September 2026).
"Cizumab EU 100 mg/4 mL Solution for infusion (1's), The Searle Company Limited — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/cizumab-eu-100-mg-4-ml-120492-1s-the-searle-company-limited/. Accessed 18 Sep 2026.
MedInfoBase. 2026. "Cizumab EU 100 mg/4 mL Solution for infusion (1's), The Searle Company Limited — registration and price record." Accessed September 18, 2026. https://medinfobase.com/brand/cizumab-eu-100-mg-4-ml-120492-1s-the-searle-company-limited/.
Price and registration data on this page were observed on 27 August 2026. Records change over time, so please cite the observation date alongside the access date.